CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 79% of retail investor accounts lose money when trading CFDs with this provider. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money.
US English
Country • Select Country
    Entity • The products and services listed on this website are not available to US residents.
    English العَرَبِيَّة Deutsch ελληνικά Español Français Italiano Magyar Nederlands Polski Română Русский 简体中文 繁體中文

    Trade Equillium, Inc. - EQ CFD

    0.5029
    0.36%
    • Summary
    • Historical Data
    • Events
    • Income Statement
    • Balance Sheet
    • Cash Flow
    • Ownership
    Trading Conditions
    Spread 0.0090
    Long position overnight fee

    Long position overnight fee

    Margin. Your investment $1,000.00
    Overnight fee -0.026207 %
    Charges from full value of position ($-4.98)
    Trade size with leverage ~ $20,000.00
    Money from leverage ~ $19,000.00
    Go to platform
    		-0.026207%
    Short position overnight fee

    Short position overnight fee

    Margin. Your investment $1,000.00
    Overnight fee 0.003985 %
    Charges from full value of position ($0.76)
    Trade size with leverage ~ $20,000.00
    Money from leverage ~ $19,000.00
    Go to platform
    		0.003985%
    Overnight fee time 22:00 (UTC)
    Min traded quantity 1
    Currency USD
    Margin 5%
    Stock exchange United States of America
    Commission on trade 0%

    *Information provided by Capital.com

    Equillium Inc ESG Risk Ratings

    High Medium Low Negligible

    ‘D’ score indicates poor relative ESG performance and insufficient degree of transparency in reporting material ESG data publicly.

    More ESG coverage

    Key Stats
    Prev. Close* 0.5011
    Open* 0.4884
    1-Year Change* -71.05%
    Day's Range* 0.4861 - 0.5029
    52 wk Range 0.45-1.76
    Average Volume (10 days) 208.21K
    Average Volume (3 months) 1.64M
    Market Cap 17.52M
    P/E Ratio -100.00K
    Shares Outstanding 35.12M
    Revenue 42.63M
    EPS -0.24
    Dividend (Yield %) N/A
    Beta 1.23
    Next Earnings Date Mar 21, 2024

    All data is provided by Refinitiv, except for data marked with an asterisk, which is *data provided by Capital.com

    • Last Week
    • Last Month
    • Last Year
    • Last two Years
    • Max
    • Daily
    • Weekly
    • Monthly
    Date Close Change Change (%) Open High Low
    Nov 28, 2023 0.5029 0.0145 2.97% 0.4884 0.5029 0.4861
    Nov 27, 2023 0.5011 0.0029 0.58% 0.4982 0.5080 0.4882
    Nov 24, 2023 0.4976 -0.0030 -0.60% 0.5006 0.5031 0.4881
    Nov 22, 2023 0.4979 0.0098 2.01% 0.4881 0.5069 0.4881
    Nov 21, 2023 0.4969 0.0088 1.80% 0.4881 0.4979 0.4881
    Nov 20, 2023 0.4932 0.0050 1.02% 0.4882 0.4982 0.4781
    Nov 17, 2023 0.4892 -0.0090 -1.81% 0.4982 0.5014 0.4781
    Nov 16, 2023 0.4813 0.0031 0.65% 0.4782 0.4813 0.4781
    Nov 15, 2023 0.4932 0.0151 3.16% 0.4781 0.5081 0.4781
    Nov 14, 2023 0.4896 0.0115 2.41% 0.4781 0.4982 0.4781
    Nov 13, 2023 0.4931 -0.0008 -0.16% 0.4939 0.5001 0.4481
    Nov 10, 2023 0.4937 -0.0240 -4.64% 0.5177 0.5494 0.4781
    Nov 9, 2023 0.4691 -0.0190 -3.89% 0.4881 0.5003 0.4691
    Nov 8, 2023 0.4931 -0.0051 -1.02% 0.4982 0.5081 0.4682
    Nov 7, 2023 0.4893 0.0002 0.04% 0.4891 0.4981 0.4891
    Nov 6, 2023 0.4931 0.0150 3.14% 0.4781 0.4981 0.4781
    Nov 3, 2023 0.4931 0.0000 0.00% 0.4931 0.5179 0.4931
    Nov 2, 2023 0.4981 0.0199 4.16% 0.4782 0.4981 0.4781
    Nov 1, 2023 0.4931 0.0090 1.86% 0.4841 0.5126 0.4841
    Oct 31, 2023 0.4941 -0.0192 -3.74% 0.5133 0.5134 0.4881

    Equillium, Inc. Events

    Time (UTC) Country Event
    Thursday, March 21, 2024

    Time (UTC)

    10:59

    Country

    US

    Event

    Q4 2023 Equillium Inc Earnings Release
    Q4 2023 Equillium Inc Earnings Release

    Forecast

    -

    Previous

    -
    View all events
    • Annual
    • Quarterly
    2022 2021 2020 2019 2018
    Total revenue 15.759 0 0 0 0
    Total Operating Expense 77.835 37.786 29.548 26.727 8.61559
    Selling/General/Admin. Expenses, Total 17.239 11.407 10.164 9.087 3.67244
    Research & Development 60.196 26.379 20.584 17.64 4.94315
    Operating Income -62.076 -37.786 -29.548 -26.727 -8.61559
    Interest Income (Expense), Net Non-Operating -0.633 -1.016 -0.623 1.112 -4.63489
    Net Income Before Taxes -62.428 -39.052 -29.813 -25.6 -13.2505
    Net Income After Taxes -62.428 -39.052 -29.813 -25.6 -13.2505
    Net Income Before Extra. Items -62.428 -39.052 -29.813 -25.6 -13.2505
    Total Extraordinary Items
    Net Income -62.428 -39.052 -29.813 -25.6 -13.2505
    Income Available to Common Excl. Extra. Items -62.428 -39.052 -29.813 -25.6 -13.2505
    Income Available to Common Incl. Extra. Items -62.428 -39.052 -29.813 -25.6 -13.2505
    Diluted Net Income -62.428 -39.052 -29.813 -25.6 -13.2505
    Diluted Weighted Average Shares 33.728 28.8063 20.3555 17.3781 12.1903
    Diluted EPS Excluding Extraordinary Items -1.85093 -1.35568 -1.46461 -1.47312 -1.08697
    Dividends per Share - Common Stock Primary Issue 0
    Diluted Normalized EPS -1.83907 -1.35568 -1.52357 -1.47312 -1.08697
    Other, Net 0.281 -0.25 0.358 0.015
    Unusual Expense (Income) 0.4 -1.2
    Revenue 15.759
    Jun 2023 Mar 2023 Dec 2022 Sep 2022 Jun 2022
    Total revenue 9.124 8.879 15.759 0 0
    Total Operating Expense 12.715 12.987 13.717 13.237 13.552
    Selling/General/Admin. Expenses, Total 3.105 3.715 5.192 4.466 4.064
    Research & Development 9.61 9.272 8.525 8.771 9.488
    Unusual Expense (Income) 0 0
    Operating Income -3.591 -4.108 2.042 -13.237 -13.552
    Interest Income (Expense), Net Non-Operating 0.368 0.407 -0.07 -0.137 -0.195
    Other, Net -0.112 -0.179 0.801 -0.281 -0.382
    Net Income Before Taxes -3.335 -3.88 2.773 -13.655 -14.129
    Net Income After Taxes -3.343 -3.94 2.773 -13.655 -14.129
    Net Income Before Extra. Items -3.343 -3.94 2.773 -13.655 -14.129
    Net Income -3.343 -3.94 2.773 -13.655 -14.129
    Income Available to Common Excl. Extra. Items -3.343 -3.94 2.773 -13.655 -14.129
    Income Available to Common Incl. Extra. Items -3.343 -3.94 2.773 -13.655 -14.129
    Diluted Net Income -3.343 -3.94 2.773 -13.655 -14.129
    Diluted Weighted Average Shares 34.4498 34.4142 34.374 34.3521 34.2926
    Diluted EPS Excluding Extraordinary Items -0.09704 -0.11449 0.08067 -0.3975 -0.41201
    Dividends per Share - Common Stock Primary Issue 0 0 0 0
    Diluted Normalized EPS -0.09704 -0.11449 0.08067 -0.3975 -0.41201
    Revenue 9.124 8.879 15.759
    • Annual
    • Quarterly
    2022 2021 2020 2019 2018
    Total Current Assets 76.735 83.37 85.174 55.431 67.0991
    Cash and Short Term Investments 71.023 80.711 82.163 53.143 65.9133
    Cash & Equivalents 59.107 50.366 23.982 13.219 28.5085
    Prepaid Expenses 2.874 2.659 3.011 2.288 1.18584
    Total Assets 78.421 85.405 85.428 55.539 67.1626
    Property/Plant/Equipment, Total - Net 1.582 1.882 0.239 0.093 0.06352
    Total Current Liabilities 32.038 8.915 7.245 3.883 2.02798
    Accounts Payable 3.977 1.225 2.766 1.873 1.11915
    Accrued Expenses 7.647 6.262 2.813 2.01 0.90883
    Notes Payable/Short Term Debt 0 0 0 0 0
    Total Liabilities 46.479 18.9 15.574 13.691 2.22751
    Total Long Term Debt 3.239 8.75 8.275 9.681 0
    Long Term Debt 3.239 8.75 8.275 9.681 0
    Other Liabilities, Total 11.202 1.235 0.054 0.127 0.19953
    Total Equity 31.942 66.505 69.854 41.848 64.9351
    Common Stock 0.003 0.002 0.002 0.001 0.00079
    Additional Paid-In Capital 204.268 176.618 141.074 82.938 80.4414
    Retained Earnings (Accumulated Deficit) -172.405 -109.977 -70.925 -41.112 -15.5124
    Total Liabilities & Shareholders’ Equity 78.421 85.405 85.428 55.539 67.1626
    Total Common Shares Outstanding 34.4142 29.4557 24.7531 17.4256 17.3762
    Short Term Investments 11.916 30.345 58.181 39.924 37.4048
    Property/Plant/Equipment, Total - Gross 1.831 2.029 0.313 0.122 0.06974
    Accumulated Depreciation, Total -0.249 -0.147 -0.074 -0.029 -0.00622
    Other Equity, Total 0.076 -0.138 -0.297 0.021 0.00528
    Other Long Term Assets, Total 0.104 0.153 0.015 0.015
    Current Port. of LT Debt/Capital Leases 5.714 1.428 1.666
    Total Receivables, Net 2.838
    Accounts Receivable - Trade, Net 2.838
    Other Current Liabilities, Total 14.7
    Sep 2023 Jun 2023 Mar 2023 Dec 2022 Sep 2022
    Total Current Assets 53.911 57.356 70.22 76.735 46.776
    Cash and Short Term Investments 46.306 48.378 61.992 71.023 44.522
    Cash & Equivalents 34.382 25.624 24.503 59.107 25.729
    Short Term Investments 11.924 22.754 37.489 11.916 18.793
    Prepaid Expenses 3.836 5.235 4.804 2.874 2.254
    Total Assets 55.225 58.764 71.79 78.421 48.631
    Property/Plant/Equipment, Total - Net 1.235 1.321 1.474 1.582 1.742
    Other Long Term Assets, Total 0.079 0.087 0.096 0.104 0.113
    Total Current Liabilities 28.199 25.218 32.02 32.038 14.93
    Accounts Payable 3.635 3.026 5.692 3.977 2.469
    Accrued Expenses 8.168 7.953 5.847 7.647 6.747
    Notes Payable/Short Term Debt 0 0 0 0 0
    Current Port. of LT Debt/Capital Leases 0 0 5.714 5.714 5.714
    Total Liabilities 31.117 31.783 42.521 46.479 20.471
    Total Long Term Debt 0 0 1.841 3.239 4.616
    Long Term Debt 0 0 1.841 3.239 4.616
    Other Liabilities, Total 2.918 6.565 8.66 11.202 0.925
    Total Equity 24.108 26.981 29.269 31.942 28.16
    Common Stock 0.003 0.003 0.003 0.003 0.003
    Additional Paid-In Capital 207.045 206.326 205.306 204.268 203.142
    Retained Earnings (Accumulated Deficit) -183.398 -179.688 -176.345 -172.405 -175.178
    Other Equity, Total 0.458 0.34 0.305 0.076 0.193
    Total Liabilities & Shareholders’ Equity 55.225 58.764 71.79 78.421 48.631
    Total Common Shares Outstanding 35.1193 34.5685 34.4142 34.4142 34.3521
    Property/Plant/Equipment, Total - Gross
    Accumulated Depreciation, Total
    Total Receivables, Net 3.769 3.743 3.424 2.838
    Accounts Receivable - Trade, Net 3.769 3.743 3.424 2.838
    Other Current Liabilities, Total 16.396 14.239 14.767 14.7
    • Annual
    • Quarterly
    2022 2021 2020 2019 2018
    Net income/Starting Line -62.428 -39.052 -29.813 -25.6 -13.2505
    Cash From Operating Activities -8.733 -32.081 -24.624 -22.949 -7.52625
    Cash From Operating Activities 0.118 0.072 0.045 0.023 0.0061
    Non-Cash Items 53.558 5.201 3.889 1.917 5.41712
    Changes in Working Capital 0.019 1.698 1.255 0.711 0.30101
    Cash From Investing Activities 18.684 27.406 -18.592 -2.166 -37.4343
    Capital Expenditures -0.279 -0.057 -0.202 -0.074 -0.03486
    Cash From Financing Activities -1.215 31.061 53.945 9.836 66.3656
    Issuance (Retirement) of Stock, Net 0.214 31.061 53.945 -0.045 64.7665
    Issuance (Retirement) of Debt, Net -1.429 0 9.881 1.59901
    Net Change in Cash 8.741 26.384 10.763 -15.289 21.405
    Other Investing Cash Flow Items, Total 18.963 27.463 -18.39 -2.092 -37.3995
    Foreign Exchange Effects 0.005 -0.002 0.034 -0.01
    Cash Interest Paid 0.847 0.836 0.839
    Mar 2023 Dec 2022 Sep 2022 Jun 2022 Mar 2022
    Net income/Starting Line -3.94 -62.428 -65.201 -51.546 -37.417
    Cash From Operating Activities -7.995 -8.733 -36.458 -23.393 -12.134
    Cash From Operating Activities 0.031 0.118 0.086 0.056 0.025
    Non-Cash Items -1.439 53.558 27.612 26.067 24.302
    Changes in Working Capital -2.647 0.019 1.045 2.03 0.956
    Cash From Investing Activities -25.181 18.684 11.706 -3.294 -11.985
    Capital Expenditures 0 -0.279 -0.277 -0.277 -0.223
    Other Investing Cash Flow Items, Total -25.181 18.963 11.983 -3.017 -11.762
    Cash From Financing Activities -1.429 -1.215 0.141 0.141 0
    Issuance (Retirement) of Stock, Net 0.214 0.141 0.141 0
    Foreign Exchange Effects 0.001 0.005 -0.026 -0.012 -0.003
    Net Change in Cash -34.604 8.741 -24.637 -26.558 -24.122
    Issuance (Retirement) of Debt, Net -1.429 -1.429
    Investor Name Investor Type Percent Outstanding Shares Held Shares change Holdings Date Turnover Rating
    Decheng Capital Management III (Cayman) LLC Investment Advisor 12.8652 4447308 0 2023-06-30 LOW
    Steel (Bruce D) Individual Investor 10.7381 3711995 0 2023-04-01 LOW
    Bradbury (Daniel M) Individual Investor 10.7381 3711995 0 2023-04-01 LOW
    Biocon SA Corporation 6.7001 2316134 0 2023-04-01 LOW
    J.P. Morgan Securities LLC Research Firm 3.4463 1191325 -427675 2023-06-30 MED
    Connelly (Stephen) Individual Investor 2.8726 993000 0 2023-04-01 LOW
    Franklin Advisers, Inc. Investment Advisor/Hedge Fund 2.5891 895000 0 2023-06-30 LOW
    The Vanguard Group, Inc. Investment Advisor/Hedge Fund 2.4211 836930 -7975 2023-06-30 LOW
    Cota Capital Management, LLC Hedge Fund 1.6266 562278 0 2023-06-30 LOW
    Tang Capital Management, LLC Hedge Fund 1.1571 400000 311432 2023-06-30 MED
    Renaissance Technologies LLC Hedge Fund 1.1346 392231 353531 2023-06-30 HIGH
    DWS Investment GmbH Investment Advisor/Hedge Fund 1.0069 348061 0 2023-06-30 LOW
    Geode Capital Management, L.L.C. Investment Advisor/Hedge Fund 0.4593 158777 0 2023-06-30 LOW
    Bridgeway Capital Management, LLC Investment Advisor 0.363 125500 0 2023-06-30 MED
    DCF Advisers, LLC Investment Advisor 0.3229 111623 -45400 2023-06-30 LOW
    Zedelmayer (Christine) Individual Investor 0.3224 111442 0 2023-04-01 LOW
    Callan Capital, LLC Investment Advisor 0.2999 103688 0 2023-06-30 LOW
    Millennium Management LLC Hedge Fund 0.2144 74104 -84674 2023-06-30 HIGH
    PGIM Quantitative Solutions LLC Investment Advisor 0.1672 57800 57800 2023-06-30 LOW
    Goldman Sachs Asset Management International Investment Advisor 0.1658 57310 21298 2022-05-31 MED

    Trading calculator

    Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).

    Trade commission
    0
    • 1:1
    Leverage
    1:1
    • 20
    • 100
    • 500
    • 1000
    • 10000
    Investment
    Trade size (Leverage x Investement):
    Open

    Close

    Short Long
    Past performance is not a reliable indicator of future results For the avoidance of doubt, this calculation does not include the costs of holding a position overnight (for which there will be additional charges)
    Profit/Loss

    For the avoidance of doubt, this calculation does not include the costs of holding a position overnight (for which there will be additional charges)

    Equillium, Inc. Company profile

    About Equillium Inc

    Equillium, Inc. is a clinical-stage biotechnology company. The Company develops products to treat severe autoimmune and inflammatory disorders with unmet medical needs. The Company's initial product candidate, itolizumab (EQ001), is a clinical-stage, monoclonal antibody that selectively targets CD6, a co-stimulatory receptor differentially expressed on subsets of pro-inflammatory T cells. The Company's CD6 plays a central role in the modulation of effector T cell, or Teff cell, activity and trafficking. Activated Teff cells drive several immuno-inflammatory diseases across therapeutic areas including transplant science, systemic autoimmunity, pulmonary, neurologic, gastrointestinal, renal, vascular, ophthalmic and dermatologic disorders. It also provides structured-domain peptides, including BNZ-1 and BNZ-2, entirely in-house from product discovery platform. These lead product candidates are multi-specific inhibitors that targets range of immuno-inflammatory indication.

    Financial summary

    BRIEF: For the fiscal year ended 31 December 2021, Equillium Inc revenues was not reported. Net loss increased 31% to $39.1M. Higher net loss reflects Research and development - Balancing val increase of 30% to $24.4M (expense), General and administrative - Balancing increase of 11% to $9M (expense), Other expense, net decrease from $358K (income) to $250K (expense).

    Industry: Pharmaceuticals (NEC)

    2223 Avenida de La Playa Ste 105
    LA JOLLA
    CALIFORNIA 92037-3217
    US

    Income Statement

    • Annual
    • Quarterly

    News

    A weaker Dollar drives gold higher

    Gold prices have returned above $US2000 per ounce. We run through the factors driving gold and the commodity’s key technicals.

    13:49, 28 November 2023

    Q3 US Earnings Recap: Profits surprise to the upside, but outlook remains uncertain

    US earnings for the third quarter were far better than expected. However, uncertainty about the outlook for company profits continues. We review the quarterly earnings and look ahead to what the markets expect from S&P 500 companies going forward.

    13:20, 28 November 2023

    RBNZ Preview: Rates expected to remain unchanged at final meeting of 2023

    The RBNZ meets for the final time this year on Wednesday, 29th of November, 2023. We preview what to expect and how it could impact the New Zealand Dollar.

    13:04, 28 November 2023

    Crude prices slide on OPEC+ uncertainty

    Crude prices have chopped sideways amid signs of turmoil within OPEC+. We look at the fundamentals of the oil market and the technical levels of WTI.

    12:55, 28 November 2023
    GBP

    UK AUTUMN BUDGET: Will Hunt cut taxes? How will GBP react this time around?

    UK Chancellor Hunt will deliver the 2023 autumn statement to MPs on Wednesday 22 November.

    10:48, 21 November 2023

    Gold Rises as Traders price-in Fed Rate Cuts

    Gold prices have declined despite a drop in Treasury yields and a weaker US Dollar. We look at the key drivers and technical levels for the gold price.

    13:17, 20 November 2023
    Gold bars

    XAU/USD Latest: Gold advances as weaker data weighs on US yields

    Gold moves higher as softer economic data weighs on US yields and the dollar

    13:43, 17 November 2023

    People also watch

    XRP/USD

    0.62 Price
    +0.430% 1D Chg, %
    Long position overnight fee -0.0753%
    Short position overnight fee 0.0069%
    Overnight fee time 22:00 (UTC)
    Spread 0.01168

    Oil - Crude

    76.50 Price
    -0.160% 1D Chg, %
    Long position overnight fee -0.0187%
    Short position overnight fee -0.0032%
    Overnight fee time 22:00 (UTC)
    Spread 0.040

    Gold

    2,042.10 Price
    +0.110% 1D Chg, %
    Long position overnight fee -0.0191%
    Short position overnight fee 0.0109%
    Overnight fee time 22:00 (UTC)
    Spread 0.30

    BTC/USD

    38,141.35 Price
    +0.340% 1D Chg, %
    Long position overnight fee -0.0616%
    Short position overnight fee 0.0137%
    Overnight fee time 22:00 (UTC)
    Spread 106.00

    Still looking for a broker you can trust?

    Join the 570.000+ traders worldwide that chose to trade with Capital.com

    1. Create & verify your account 2. Make your first deposit 3. You’re all set. Start trading